Biotechnology
Homocysteine Reagents Market

Homocysteine Reagents Market

Homocysteine Reagents Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

ID: PMRREP30719

Upcoming

Author : Pravin Rewale

Healthcare

Introduction

Homocysteine reagents are used to determine the level of the homocysteine in human serum or plasma. Homocysteine amino acid biosynthesized as an intermediary product of methionine metabolism. Homocysteine reagents are intended for the quantitative measurement of the homocysteine level and assist in the diagnosis and management of patients supposed of having homocystinuria and hyperhomocysteinemia.

Homocystinuria is the disorder which leads to abnormal accumulation of homocysteine and its metabolites in urine and blood. Hyperhomocysteinemia is characterized by a high level of homocysteine in the blood above 15 µmol/L.

Hyperhomocysteinemia can be the reason for several conditions such as cardiovascular diseases, neurological diseases, and vascular disease. Homocysteine reagents used in the diagnosis of cardiovascular diseases such as (hypertension, stroke, ischemic heart disease, neurological diseases such as (Parkinson’s disease, Alzheimer’s disease, epilepsy), and vascular diseases (deep vein thrombosis, pulmonary embolism) and others.

Homocysteine reagents are most commonly used to predict the risk of cardiac disorders and it is an early risk marker for high-risk patients. Homocysteine testing has become an accurate way to predict various health risks such as neural tube defects, deep vein thrombosis, learning disorders in young people, risk of arteriosclerosis, dementia and stroke.

Increasing recommendation for the regular cardiac parameter and risk assessment by healthcare professionals and growing awareness among general population expected to boost up the growth of the homocysteine reagents market.

Increasing cardiovascular disease and neurological disorders expected to boost up the demand for the homocysteine reagents for the accurate diagnosis of the condition. Introduction of the new testing method, adoption of new technologies for diagnostic testing influence the growth of the homocysteine reagents market.

Growing healthcare parameter testing campaign and increasing per capita healthcare expenditure expected to drive the growth of the homocysteine reagents market. Increasing funding for diagnostic laboratories in the rural and underdeveloped region expected to favour the growth of the homocysteine reagents market.

Increasing prevalence of heart disorder among the older population and improving reimbursement for cardiovascular screening boost up the growth of the homocysteine reagents market.